IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NPS Pharmaceuticals Inc

CUSIP: 62936P10 | 4 institutional holders

Quarters

Q1 2014Q4 2013Q2 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2014

Arrowstreet Capital, Limited Partnership135,820
0.0% of portfolio›$4.1K
StyleTurnoverLocationFiled
Arrowstreet Capital, Limited Partnership
135,820$4.1K0.0%GARPHighBoston, MA2014-05-15